Hyperhidrosis Epidemiology Forecast 2025-2034

The International Hyperhidrosis Society reports that around 385 million people worldwide have hyperhidrosis, a condition characterized by excessive sweating. It is more common in younger people, affecting 8.8% of individuals aged 18 to 39. Hyperhidrosis epidemiology forecast indicates that hyperhidrosis often begins in early adulthood or adolescence.

Hyperhidrosis Epidemiology Forecast Report Coverage

The “Hyperhidrosis Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of hyperhidrosis. It projects the future incidence and prevalence rates of hyperhidrosis across various populations. The study covers age, gender, and type as major determinants of the hyperhidrosis-affected population. The report highlights patterns in the prevalence of hyperhidrosis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hyperhidrosis in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Hyperhidrosis Understanding: Disease Overview

In hyperhidrosis, a person sweats excessively, even when it is not needed to regulate body temperature. This can happen in specific areas, such as the hands, feet, armpits, or face, or it can affect the whole body. There are two main types of hyperhidrosis: primary, which is typically inherited, and secondary, which is caused by other health conditions or medications. Hyperhidrosis can interfere with daily activities and social situations, with people often experiencing embarrassment and discomfort due to the constant sweating. Studies show that hyperhidrosis can be triggered by stress, heat, or certain medications.

Hyperhidrosis Epidemiology Perspective

The hyperhidrosis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for hyperhidrosis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hyperhidrosis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• As per the International Hyperhidrosis Society, nearly 385 million people are affected by hyperhidrosis across the globe.
• Primary focal hyperhidrosis is the most common type of hyperhidrosis and is reported to usually start before age 25.
• In the United States, approximately 3% of adults aged between 20 and 60 are living with hyperhidrosis.

Age-Based Hyperhidrosis Insights

Studies show that hyperhidrosis is significantly more common in younger individuals compared to the general population. It is estimated that about 8.8% of people between the ages of 18 and 39 experience this condition. This higher prevalence in younger adults suggests that hyperhidrosis often begins during adolescence or early adulthood.

Gender-Based Hyperhidrosis Insights

A study published in the Journal of Marine Medical Society (2024) found that hyperhidrosis was more common in males, with a male-to-female ratio of 1.4:1 and a prevalence of 2.6% in Indian patients. The average age of presentation was 24.5 years, with 90% of patients experiencing the onset of symptoms before the age of 30.

Country-wise Hyperhidrosis Epidemiology Segment

The hyperhidrosis epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of hyperhidrosis varies between countries, owing to differences in factors such as climate, genetics, lifestyle, healthcare access, and cultural attitudes toward sweating and medical treatments. According to a 2023 review published in the Journal of Dermatology, the incidence of hyperhidrosis varied from 0.13% in the United Kingdom to 0.28% in the USA, with females showing higher rates.

Key Questions Answered

• What are the key findings of hyperhidrosis epidemiology in the 8 major markets?
• What will be the total number of patients with hyperhidrosis across the 8 major markets during the forecast period?
• What was the country-wise prevalence of hyperhidrosis in the 8 major markets in the historical period?
• Which country will have the highest number of hyperhidrosis patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of hyperhidrosis during the forecast period of 2025-2034?
• What are the currently available treatments for hyperhidrosis?
• What are the disease risks, signs, symptoms, and unmet needs of hyperhidrosis?

This product will be delivered within 3-5 business days.